Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Acros…

Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) ...

Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximiz…

Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s ...
Packaging News

Renaissance, Biome partner on renewable bioplastics

Renaissance BioScience and Biome Bioplastics are working together on a two-year Canada–UK project to develop renewable ...